Breaking Regulatory Compliance
FINRA's Spartan Capital Case: The Private-Placement Diligence File That Wasn't There
FINRA fined Spartan Capital $1M and ordered $2.18M restitution over Reg BI private-placement failures. The diligence file and markup controls to build.
Table of Contents
TL;DR
- FINRA ordered Spartan Capital Securities — a Manhattan broker-dealer with roughly 5,000 retail accounts — to pay $2.18 million in restitution and a $1 million fine over 16 private placements sold to 186 customers. Its former CEO got a two-year suspension. Its former acting CCO was barred outright.
- The firm made 344 recommendations worth about $24 million and pulled in more than $2.3 million in placement fees while, per FINRA, never establishing a reasonable basis for any of it. The Care Obligation breach was charged as willful.
- The structure is the lesson: the CEO also solely owned the issuer funds, set the 10% placement fee, and priced the markups. The CCO was simultaneously president of those same funds.
- Markups ran as high as 36% and $3.25 million of them flowed to the CEO. One offering was priced $185 a share above what the fund paid — a 12.75% spread the PPM effectively hid.
- The fix is unglamorous: a diligence file that proves you checked upstream ownership, a markup reconciliation that runs before pricing is loaded, and a conflicts register with names on it.
The number that should stop you
$3.25 million.
That’s the total markups FINRA says Spartan Capital charged across the Atlas Funds offerings, and it’s the number that explains the rest of the order. Not the fine. Not the restitution. The markups are where the money actually went, and they went to the person who controlled both sides of the trade.
The order came down November 17, resolving a disciplinary complaint filed November 24, 2025. Spartan, former CEO and majority owner John Lowry, and former acting CCO and chief administrative officer Kim Monchik all consented to the findings without admitting or denying them, under FINRA Rule 9270(e)(3).
Here’s what that actually looked like inside the firm, because the mechanics matter more than the headline.
The structure, drawn plainly
Between March and October 2021, Spartan made 344 recommendations across 16 private placements — roughly $24 million in principal value to 186 customers, most of them retail. The offerings were interests in three unregistered funds: Atlas Fund III, IV, and V, LLC, managed by Atlas Fund Management LLC.
Lowry solely owned and controlled both the funds and the management company. He selected which pre-IPO company each series would target. He negotiated investment amounts and prices. At his direction, Spartan was the exclusive placement agent, and it retained a 10% placement fee on top of a 2% management fee and 20% carried interest to the fund manager.
The funds then bought interests in SP Venture Fund 8, LLC — the “StraightPath Fund” — managed by StraightPath Venture Partners. The customer’s money passed through two entities, both priced along the way, before touching anything resembling a pre-IPO share.
| Layer | Who controlled it | What they took |
|---|---|---|
| Spartan Capital (placement agent) | Lowry, majority owner | 10% placement fee |
| Atlas Fund Management (fund manager) | Lowry, sole owner | 2% management fee, 20% carry |
| Atlas Fund III/IV/V | Lowry, sole owner and control person | $3.25M in markups |
| SP Venture Fund 8 / StraightPath | Third party | Undisclosed to Spartan, per FINRA |
Spartan and the Atlas entities shared office space and staff. Monchik, the firm’s CCO, also served as president of the Atlas entities and spent roughly 40% of her time there from July 2020 onward, drawing no direct Atlas compensation — she was paid through Spartan, by Lowry.
What FINRA says was missing
Read the order as a list of documents that should have existed and didn’t.
Spartan and Monchik, per FINRA, never determined whether StraightPath actually possessed or had access to shares of the underlying pre-IPO companies. They never reasonably investigated StraightPath’s operating history or the backgrounds of its principals. They never evaluated the offerings’ pricing, including whether StraightPath applied markups to what it sold into the Atlas Funds. And they never fully disclosed Lowry’s ownership, his economic incentive, or Monchik’s dual role.
That combination gave the firm, in FINRA’s words, no reasonable basis for concluding the recommendations were in customers’ best interest — a willful violation of Reg BI’s Care Obligation under Exchange Act Rule 15l-1(a)(1), plus FINRA Rule 2111 and Rule 2010.
The offering documents compounded it. The PPMs and supplements told investors that a third-party affiliate would sell interests to the Atlas Funds at a markup and that the funds would not share in markup profits. In reality the funds bought directly from StraightPath, charged markups, and the markup profits landed with entities Lowry owned and controlled. FINRA charged that as a Rule 2010 violation contravening Sections 17(a)(2)–(3) of the Securities Act.
The cleanest illustration sits in the order. For one underlying company, Lowry negotiated a purchase price equivalent to $1,450 a share, then priced the offering at $1,635. That’s $185 a share, 12.75% higher, and per InvestmentNews, markups across the offerings ranged from 13% to 36%.
Why “willful” is the word to underline
A negligence finding says the process slipped. A willful finding says the firm had what it needed to know better.
Reg BI’s Care Obligation, as SEC staff framed it in the 2023 Staff Bulletin on Care Obligations, requires a reasonable investigation into the security sufficient not to base a recommendation on materially inaccurate or incomplete information — and cost, including fees and markups, is squarely part of that analysis. FINRA Regulatory Notice 23-08 says the same thing in operational terms: a member recommending a private placement must investigate the issuer and the offering, must act on red flags, and must have WSPs reasonably designed to ensure each offering is supervised before it is marketed.
Twelve percent to thirty-six percent of undisclosed spread is not a rounding issue. It is the price of the thing being sold.
The red flag that was publicly available
StraightPath’s principals had history. Michael Castillero and Francine Lanaia had both been barred from the securities industry by FINRA — and per the DOJ’s sentencing announcement, the StraightPath operators concealed that fact while running boiler-room call centers that raised roughly $400 million. Castillero, Brian Martinsen, and Lanaia were sentenced in May 2026 to 11, 10, and 8 years respectively, with $115 million in joint restitution. Two of them also destroyed records during the SEC’s investigation.
Two phone calls and a BrokerCheck pull would have surfaced barred principals. That is the standard Spartan missed, and it is not a sophisticated one.
Building the file that survives an exam
If your firm sells Reg D placements — especially for an affiliate — the diligence artifact matters more than the diligence intention. What follows is a starter structure to calibrate against your own deal flow, not a rulebook.
| Artifact | What it proves | Who signs |
|---|---|---|
| Upstream ownership verification (custodian or transfer-agent confirmation that the fund holds or can access the shares) | The thing being sold exists | Deal lead + CCO |
| Principals and control-person background check (BrokerCheck, Form BD, litigation search, bar history) | No disqualifying history, or a documented decision to proceed anyway | Compliance analyst |
| Markup reconciliation: upstream purchase price → fund entry price → customer price, with each delta labeled | The spread and who earns it | Finance + CCO |
| Conflicts register naming every affiliated party, their role, and their compensation | No conflict is unnamed | CCO |
| PPM-to-economics tie-out: line-by-line check that the disclosure paragraph matches the actual flow of funds | Disclosure isn’t decorative | CCO |
| Independent price reasonableness check against a comparable offering | The price isn’t just what the control person wants | Deal lead |
| Dated, versioned supervisory sign-off before first sale | Someone with authority, at a point in time | Principal / CCO |
Two design notes. First, the markup reconciliation has to run before pricing loads into the order system, not after. A reconciliation completed post-trade is a reporting control; one completed pre-trade is a pricing control. Second, the signer has to be someone whose comp isn’t tied to the deal closing. At a small firm that usually means the CCO, which raises the next problem.
The CCO wearing two hats
Monchik spent 40% of her time running the issuer that Spartan was selling and was compensated by the person who owned both. FINRA found she was responsible for Spartan’s due diligence on offerings she was simultaneously operating.
That arrangement is common at small broker-dealers with affiliated funds. It is also structurally compromised, and the order treats it as such rather than as an excuse. If your CCO has an issuer-side title, run this test:
- Write down every offering decision the CCO touches on the issuer side: pricing, PPM language, fund formation, share acquisition.
- For each, name the person who independently reviews the CCO’s work on the broker-dealer side. If the answer is the CEO who owns the issuer, you have a gap.
- Add an outside reviewer — counsel, a compliance consultant, or an independent FINRA-member principal — for the pricing and disclosure tie-out on every affiliated offering.
- Document the capacity split in the WSPs, with hours and reporting lines. “Wears two hats” in a policy is not a control; “40% of time, no separate compensation, reviewed by X” is.
- Disclose the dual role to customers in the offering documents, not just in the conflicts section of the ADV.
If your firm already has history
Spartan was not a first-time respondent. FINRA’s order recites an October 2024 NAC decision affirming that Lowry and Monchik willfully failed to amend Forms U4 to disclose customer arbitrations — two-year suspensions and $20,000 and $10,000 fines — and a March 2026 extended hearing panel decision on supervision and untimely Rule 8210 document production, which added another $50,000 fine and further suspensions.
That pattern should change how you read your own record. A firm with a U4 or Rule 8210 finding has already told the regulator that its paperwork and its responses are unreliable. The next exam starts from that premise. Pull your last three disciplinary matters, cluster them by root cause rather than by rule number, and check whether the remediation from matter one would have prevented matter three. In Spartan’s case the answer appears to have been no.
The sanctions
| Respondent | Role | Sanction |
|---|---|---|
| Spartan Capital Securities, LLC | Member firm (CRD 146251) | $2.18M restitution, $1M fine |
| John Lowry | Co-founder, majority owner, CEO 2014–May 2026 (CRD 4336146) | $25,000 fine, two-year suspension in all capacities |
| Kim Monchik | CAO; CCO during the period (CRD 2528972) | Barred from associating with any FINRA member firm |
Findings become part of each respondent’s permanent disciplinary record. InvestmentNews put the restitution near 10% of the dollar value of placements sold to clients in the matter.
So what
The uncomfortable part of this order is that nothing in it required a novel legal theory. A broker-dealer sold affiliate-issued funds, charged a spread on top of disclosed fees, described the spread inaccurately in the PPM, and never verified that the underlying asset existed. Every one of those failures was checkable with documents the firm already had access to.
Three things to do this quarter, in order:
Days 1–30. Pull every open or recent private placement where an affiliate, control person, or the CEO has an ownership interest. For each, locate the upstream ownership evidence and the markup reconciliation. If either is missing, stop new sales into that offering until it’s produced.
Days 31–60. Rebuild the conflicts register with names, roles, and compensation rather than categories. Reconcile the register against the PPM disclosure paragraph line by line and log every mismatch as an issue with an owner and a due date.
Days 61–90. Add the independent reviewer to the affiliated-offering workflow, amend the WSPs to describe the CCO capacity split in operational terms, and run one tabletop where the deal lead’s pricing is challenged by someone who doesn’t report to them.
If you need a structure to hold the gaps, owners, and target dates while you work through that list, the RCSA template is built for exactly this: control-by-control assessment with the evidence field attached.
FAQ
What did FINRA order Spartan Capital to pay?
FINRA ordered the firm to pay $2.18 million in restitution to 186 customers and a $1 million fine — $3.18 million total. Lowry was separately fined $25,000 and suspended two years in all capacities; Monchik was barred from any FINRA member firm.
Is this a Reg BI case or a suitability case?
Both, plus antifraud. The Care Obligation charge was brought under Reg BI and marked willful. FINRA charged Rule 2111 alongside — it still governs recommendations outside Reg BI’s retail-customer scope — plus Rule 2010, and charged the misleading PPM language as contravening Securities Act Sections 17(a)(2)–(3).
Do the respondents admit the findings?
No. All three consented without admitting or denying, which is standard in FINRA settlement orders. The findings still become part of their permanent disciplinary records and can be used in later actions.
Does this apply to firms that only occasionally sell placements?
Reg BI applies to recommendations to retail customers regardless of volume, and Regulatory Notice 23-08 notes that SEC staff has emphasized the rule’s application to limited-purpose broker-dealers recommending private offerings to accredited investors. Occasional sellers are not exempt; they just have fewer deals to document.
What’s the single highest-value control here?
The pre-trade markup reconciliation with a named signer. It simultaneously tests whether the upstream asset exists, whether the spread is disclosed accurately, and whether anyone independent of the deal looked at the price before a customer did.
◆ Immaterial Findings · Weekly
Sharp risk & compliance insights. No fluff.
◆ FAQ
Frequently asked questions.
What did FINRA order Spartan Capital to pay?
What is the difference between a Reg BI Care Obligation failure and a suitability failure?
Does a placement agent have to diligence a fund manager it does not control?
What does a defensible private-placement diligence file contain?
Was Spartan Capital a repeat offender?
Author
Rebecca Leung
Rebecca Leung has 8+ years of risk and compliance experience across first and second line roles at commercial banks, asset managers, and fintechs. Former management consultant advising financial institutions on risk strategy. Founder of RiskTemplates.
● Don't wait for your own enforcement action
Every case like this started with a gap someone knew about but hadn't documented. The template below gives you the framework to get ahead of it.
RCSA (Risk & Control Self-Assessment)
141 fintech risks with mapped controls, a 97-question self-assessment, control testing plan, challenge log and a one-page Board Summary.
◆ Keep reading
Related posts.
Regulatory Compliance
The FinCEN MEXC Order: What Covered Institutions Must Prove by December 10
The FinCEN MEXC order blocks all fund transmittals involving MEXC Global starting Dec. 10, 2026. Here's the control and evidence work it creates.
Nov 13, 2026
Regulatory Compliance
DOJ WHIP Whistleblower Rewards Put a 120-Day Clock on Internal Investigations
DOJ's WHIP whistleblower rewards pay $10,000-$30,000 after charges. The 120-day rule changes internal fraud investigation priorities.
Oct 21, 2026
Regulatory Compliance
OCC GENIUS Act Final Rule: The Stablecoin Controls That Must Work by January 18
The OCC GENIUS Act final rule sets reserve, redemption, capital, reporting, and waiver requirements effective January 18, 2027.
Oct 21, 2026